More about

Pancreatic Ductal Adenocarcinoma

News
November 14, 2022
1 min read
Save

Onivyde regimen extends OS in metastatic pancreatic ductal adenocarcinoma

An irinotecan liposome injection regimen improved OS compared with standard chemotherapy among untreated patients with metastatic pancreatic ductal adenocarcinoma, according to the agent’s manufacturer.

News
September 01, 2022
2 min read
Save

Modified FOLFIRINOX ‘recommended adjuvant regimen’ for patients with pancreatic cancer

Adjuvant chemotherapy with modified FOLFIRINOX resulted in significantly longer survival vs. gemcitabine among patients with previously resected pancreatic ductal adenocarcinoma, according to 5-year data from a randomized phase 3 study.

News
March 08, 2022
1 min read
Save

Stool-based screening shows promise in early detection of pancreatic cancer

Fecal microbiota-based screening may help with early detection of pancreatic ductal adenocarcinoma, according to a study published in Gut.

News
September 27, 2021
1 min read
Save

FDA grants orphan drug designation to nadunolimab for pancreatic cancer

The FDA granted orphan drug designation to nadunolimab for the treatment of pancreatic cancer.

News
June 25, 2021
1 min read
Save

pSTAT3 expression reliable marker of poor prognosis for gastric cancer

Gastric cancer populations that show higher rates of phosphorylated signal transducer and activator of transcription 3 were more likely to have a shorter medial overall survival rate , according to data from a three phase 3 clinical trials presented at ASCO.

News
July 06, 2020
4 min read
Save

Liquid biopsy shows promise for early detection of pancreatic cancer

A liquid biopsy has shown promise for the early detection and staging of pancreatic ductal adenocarcinoma.

News
June 17, 2020
1 min read
Save

FDA grants fast track designation to Onivyde for advanced pancreatic cancer

The FDA granted fast track designation to liposomal irinotecan as part of a first-line combination for the treatment of adults with previously untreated, unresectable, locally advanced and metastatic pancreatic ductal adenocarcinoma.

News
May 22, 2020
2 min read
Save

Neoadjuvant therapy-induced sarcopenia, reduced OS linked in pancreatic ductal adenocarcinoma

Neoadjuvant therapy-induced sarcopenia in patients who underwent neoadjuvant therapy for pancreatic ductal adenocarcinoma correlated with increased disease recurrence and overall mortality, and reduced overall survival, according to a presentation from Digestive Disease Week.

News
March 20, 2020
3 min read
Save

Improvements in screening may be linked to increase in early-stage pancreatic cancer diagnoses

Increases in the proportion of patients diagnosed with pancreatic cancer at an earlier stage and younger age may be due to improvements in early detection and diagnosis, according to study results published in Journal of National Cancer Institute.

News
January 03, 2020
1 min read
Save

Early VTE linked with worse survival in pancreatic ductal adenocarcinoma

Frequent and early onset of venous thromboembolism are associated with decreased progression-free survival and overall survival among patients diagnosed with pancreatic ductal adenocarcinoma, according to study results.

View more